Cancer Chemotherapy and Biotherapy: Principles and Practice, 4th ed.0781756286 Cancer chemotherapy and biotherapy; principles and practice, 4th ed. Ed. by Bruce A. Chabner and Dan L. Longo. Lippincott Williams & Wilkins 2006 879 pages $199.00 Hardcover RC271 Chabner (clinical director, Cancer Center, Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world ) and Longo (scientific director, National Institute on Aging The National Institute on Aging is a division of the U.S. National Institutes of Health, located in Bethesda, Maryland. Formed in 1974, NIA's mission is to improve the health and well-being of older Americans through research. It is the primary U.S. ) present 37 papers detailing the current knowledge related to cancer chemotherapy and biotherapy. The bulk of the work consists of reviews of the characteristics and uses of the different types of drugs and chemical and biological agents important to the field, including antifolates, cytidine cytidine /cy·ti·dine/ (si´ti-den) a purine nucleoside consisting of cytosine and ribose, a constituent of RNA and important in the synthesis of a variety of lipid derivatives. Symbol C. analogues, purine antimetabolites, bleomycin, antitumor antibiotics, asparaginase asparaginase /as·par·a·gin·ase/ (as-par´ah-jin-as?) an enzyme that catalyzes the deamination of asparagine; a preparation is used as an antineoplastic agent in acute lymphoblastic leukemia to reduce availability of asparagine to tumor , bisphosphonates, inhibitors of tumor angiogenesis, interferons, and interleukins, to cite a few. Some chapters are broader in scope, discussing such topics as clinical strategies for cancer treatment, preclinical aspects of cancer drug discovery, pharmacokinetics, infertility after cancer chemotherapy, carcinogenesis of anticancer drugs, antibody therapies of cancer, hematopoietic hematopoietic /he·ma·to·poi·et·ic/ (-poi-et´ik) 1. pertaining to hematopoiesis. 2. an agent that promotes hematopoiesis. hematopoietic 1. pertaining to or affecting the formation of blood cells. growth factors, the role of the Food and Drug Administration in oncology product development, and hormonal therapy for breast cancer. ([c]20062005 Book News, Inc., Portland, OR) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion